| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 喹喏酮产品(元) | 34,274,658.37 | 45,927,151.71 | 22,996,795.16 | 53,600,030.32 | 25,136,629.69 |
| 造影剂产品(元) | 1,068,159,033.63 | 1,816,591,132.69 | 888,244,940.15 | 1,752,811,931.66 | 762,640,094.16 |
| CDMO系列(元) | - | 97,245,380.77 | - | 51,852,440.01 | - |
| CMO/CDMO(元) | 35,414,398.26 | - | - | - | - |
| 其他(元) | 39,731,488.24 | 35,823,991.56 | 39,517,119.33 | 9,368,278.21 | 20,120,096.35 |
| 营业成本(元) | |||||
| 喹喏酮产品(元) | 31,298,867.15 | 41,536,905.11 | 20,452,700.79 | 45,986,569.42 | 21,487,440.54 |
| 造影剂产品(元) | 824,145,165.36 | 1,331,009,708.76 | 661,933,436.79 | 1,298,582,972.98 | 516,268,138.92 |
| CDMO系列(元) | - | 84,158,105.35 | - | 43,218,771.39 | - |
| CMO/CDMO(元) | 30,143,792.19 | - | - | - | - |
| 其他(元) | 11,089,521.96 | 15,206,445.79 | 26,879,739.12 | 16,571,028.29 | 15,572,857.40 |
| 毛利(元) | |||||
| 喹喏酮产品(元) | 2,975,791.22 | 4,390,246.60 | 2,544,094.37 | 7,613,460.90 | 3,649,189.15 |
| 造影剂产品(元) | 244,013,868.27 | 485,581,423.93 | 226,311,503.36 | 454,228,958.68 | 246,371,955.24 |
| CDMO系列(元) | - | 13,087,275.42 | - | 8,633,668.62 | - |
| CMO/CDMO(元) | 5,270,606.07 | - | - | - | - |
| 其他(元) | 28,641,966.28 | 20,617,545.77 | 12,637,380.21 | -7,202,750.08 | 4,547,238.95 |
| 毛利率(%) | |||||
| 喹喏酮产品(%) | 8.68 | 9.56 | 11.06 | 14.20 | 14.52 |
| 造影剂产品(%) | 22.84 | 26.73 | 25.48 | 25.91 | 32.31 |
| CDMO系列(%) | - | 13.46 | - | 16.65 | - |
| CMO/CDMO(%) | 14.88 | - | - | - | - |
| 其他(%) | 72.09 | 57.55 | 31.98 | -76.88 | 22.60 |
| 收入构成(%) | |||||
| 喹喏酮产品(%) | 2.91 | 2.30 | 2.42 | 2.87 | 3.11 |
| 造影剂产品(%) | 90.71 | 91.03 | 93.42 | 93.85 | 94.40 |
| CDMO系列(%) | - | 4.87 | - | 2.78 | - |
| CMO/CDMO(%) | 3.01 | - | - | - | - |
| 其他(%) | 3.37 | 1.80 | 4.16 | 0.50 | 2.49 |
| 毛利构成(%) | |||||
| 喹喏酮产品(%) | 1.06 | 0.84 | 1.05 | 1.64 | 1.43 |
| 造影剂产品(%) | 86.87 | 92.73 | 93.71 | 98.05 | 96.78 |
| CDMO系列(%) | - | 2.50 | - | 1.86 | - |
| CMO/CDMO(%) | 1.88 | - | - | - | - |
| 其他(%) | 10.20 | 3.94 | 5.23 | -1.55 | 1.79 |